000597 东北制药
已收盘 04-29 15:00:00
资讯
新帖
简况
东北制药(000597)2026年一季报简析:增收不增利
证券之星 · 04-29 07:57
东北制药(000597)2026年一季报简析:增收不增利
图解东北制药一季报:第一季度单季净利润同比下降26.68%
证券之星 · 04-28 04:55
图解东北制药一季报:第一季度单季净利润同比下降26.68%
东北制药(000597)披露2025年度股东会决议公告,4月27日股价下跌0.6%
证券之星 · 04-27 18:36
东北制药(000597)披露2025年度股东会决议公告,4月27日股价下跌0.6%
东北制药营收利润双降背后:传统主业失速与创新转型阵痛并存 外部竞争加剧、内部风险凸显
新浪证券 · 04-16
东北制药营收利润双降背后:传统主业失速与创新转型阵痛并存 外部竞争加剧、内部风险凸显
东北制药的“双降”困局:仿制药承压,创新药“烧钱”
新浪证券 · 04-10
东北制药的“双降”困局:仿制药承压,创新药“烧钱”
东北制药(000597)3月31日股东户数4.75万户,较上期减少1.17%
中金财经 · 04-03
东北制药(000597)3月31日股东户数4.75万户,较上期减少1.17%
东北制药(000597.SZ)发布2025年度业绩,归母净利润2.6亿元,下降36.54%
智通财经 · 04-02
东北制药(000597.SZ)发布2025年度业绩,归母净利润2.6亿元,下降36.54%
股市必读:东北制药(000597)3月23日收盘跌7.45%,主力净流出560.69万元
证券之星 · 03-24
股市必读:东北制药(000597)3月23日收盘跌7.45%,主力净流出560.69万元
东北制药:截至2026年3月10日持有人数约4.81万
证券之星 · 03-18
东北制药:截至2026年3月10日持有人数约4.81万
东北制药:DCTY1102注射液是一款适应症为晚期胰腺癌、结直肠癌等恶性肿瘤的自体TCR-T细胞免疫治疗产品
证券之星 · 03-18
东北制药:DCTY1102注射液是一款适应症为晚期胰腺癌、结直肠癌等恶性肿瘤的自体TCR-T细胞免疫治疗产品
东北制药(000597)披露2026年第一次临时股东会决议公告,3月4日股价下跌1.35%
证券之星 · 03-04
东北制药(000597)披露2026年第一次临时股东会决议公告,3月4日股价下跌1.35%
东北制药(000597)披露关于修订《公司章程》的议案,2月24日股价上涨0.19%
证券之星 · 02-24
东北制药(000597)披露关于修订《公司章程》的议案,2月24日股价上涨0.19%
东北制药:截至2026年1月30日,持有人数约4.87万
证券之星 · 02-05
东北制药:截至2026年1月30日,持有人数约4.87万
东北制药(000597)披露诉讼进展公告,2月2日股价下跌2.83%
证券之星 · 02-02
东北制药(000597)披露诉讼进展公告,2月2日股价下跌2.83%
东北制药:截至2025年12月31日持有人数约4.74万
证券之星 · 01-08
东北制药:截至2025年12月31日持有人数约4.74万
东北制药(000597)披露非独立董事辞职暨选举职工代表董事公告,1月6日股价上涨0.38%
证券之星 · 01-06
东北制药(000597)披露非独立董事辞职暨选举职工代表董事公告,1月6日股价上涨0.38%
东北制药:截至2025年12月19日持有人数约4.80万
证券之星 · 2025-12-24
东北制药:截至2025年12月19日持有人数约4.80万
东北制药最新公告:开展股东回馈活动
证券之星 · 2025-12-23
东北制药最新公告:开展股东回馈活动
东北制药:截至2025年12月10日持有人数约4.80万
证券之星 · 2025-12-19
东北制药:截至2025年12月10日持有人数约4.80万
东北制药(000597)披露取消监事会及修订公司章程等议案获股东会通过,12月15日股价下跌1.31%
证券之星 · 2025-12-15
东北制药(000597)披露取消监事会及修订公司章程等议案获股东会通过,12月15日股价下跌1.31%
加载更多
公司概况
公司名称:
东北制药集团股份有限公司
所属行业:
医药制造业
上市日期:
1996-05-23
主营业务:
东北制药集团股份有限公司的主营业务是化学制药、医药商业、医药工程、生物医药等板块。公司的主要产品是维生素类、抗感染类、生殖系统和性激素类产维生素C系列、维生素B1、维生素B6和左卡尼汀系列、磷霉素系列、阿奇霉素系列、金刚烷胺系列、盐酸小檗碱、氯霉素、卡孕栓、卡前列素氨丁三醇、左炔诺孕酮片、他达拉非片、盐酸达泊西汀、吡拉西坦系列、左乙拉西坦系列、长春西汀、盐酸吗啡注射液、盐酸吗啡片、盐酸羟考酮注射液、复方甘草系列、氨酚待因片、克度/齐多夫定片、克度/齐多夫定胶囊、依非韦伦、齐多拉米双夫定片、地衣芽孢杆菌、铝碳酸镁咀嚼片、复方丙谷胺西咪替丁片、对乙酰氨基酚片、去痛片、非那西丁、普瑞巴林、那可丁糖浆、枸磺新啶片、甲硝唑片、替硝唑片、马来酸氨氯地平、维格列汀、恩格列净、氨酚伪麻那敏口服溶液、氨酚烷胺片、HIV、HBV、HCV、HPV、TB分子诊断试剂、养颜护肤系列化妆品、药食同源功能饼干、细胞治疗产品、神经系统类产品、抗艾滋病类产品、消化道类产品、麻精及含麻系列类产品、其他普药类产品、体外诊断试剂类产品、大健康领域产品。公司是中国重要的药品生产与出口基地、中国最大的单体制剂生产基地之一、中国麻精药品和抗艾药物生产基地、国家大宗原料药和医药中间体智能制造示范工厂、国家级企业技术中心和创新药物孵化基地、国际医药食品市场主流供应商。
发行价格:
6.68
{"stockData":{"symbol":"000597","market":"SZ","secType":"STK","nameCN":"东北制药","latestPrice":4.96,"timestamp":1777446189000,"preClose":4.95,"halted":0,"volume":13129200,"delay":0,"changeRate":0.002,"floatShares":1409000000,"shares":1427000000,"eps":0.1755,"marketStatus":"已收盘","change":0.01,"latestTime":"04-29 15:00:00","open":4.95,"high":4.99,"low":4.93,"amount":65208500,"amplitude":0.0121,"askPrice":4.97,"askSize":988,"bidPrice":4.96,"bidSize":1674,"shortable":0,"etf":0,"ttmEps":0.1755,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777512600000},"marketStatusCode":5,"adr":0,"adjPreClose":4.95,"symbolType":"stock","openAndCloseTimeList":[[1777426200000,1777433400000],[1777438800000,1777446000000]],"highLimit":5.45,"lowLimit":4.46,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1427088265,"isCdr":false,"pbRate":1.27,"roa":"--","peRate":28.262108,"roe":"0.48%","epsLYR":0.18,"committee":0.531642,"marketValue":7078000000,"turnoverRate":0.0093,"status":0,"floatMarketCap":6990000000},"requestUrl":"/m/hq/s/000597","defaultTab":"news","newsList":[{"id":"2631583135","title":"东北制药(000597)2026年一季报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2631583135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631583135?lang=zh_cn&edition=full","pubTime":"2026-04-29 07:57","pubTimestamp":1777420631,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期东北制药发布2026年一季报。根据财报显示,东北制药增收不增利。截至本报告期末,公司营业总收入20.06亿元,同比上升3.03%,归母净利润2663.11万元,同比下降26.68%。本次财报公布的各项数据指标表现一般。去年的净利率为3.08%,算上全部成本后,公司产品或服务的附加值不高。生意拆解:公司过去三年净经营资产收益率分别为20.7%/16.8%/6.8%,净经营利润分别为3.76亿/4.23亿/2.18亿元,净经营资产分别为18.13亿/25.14亿/31.92亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900024468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597","BK0239","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630310040","title":"图解东北制药一季报:第一季度单季净利润同比下降26.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630310040","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630310040?lang=zh_cn&edition=full","pubTime":"2026-04-28 04:55","pubTimestamp":1777323355,"startTime":"0","endTime":"0","summary":"证券之星消息,东北制药2026年一季报显示,一季度公司主营收入20.06亿元,同比上升3.03%;归母净利润2663.11万元,同比下降26.68%;扣非净利润1477.49万元,同比下降25.78%;负债率58.17%,投资收益-23.28万元,财务费用2056.43万元,毛利率28.44%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800013200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630606823","title":"东北制药(000597)披露2025年度股东会决议公告,4月27日股价下跌0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630606823","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630606823?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:36","pubTimestamp":1777286202,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘,东北制药报收于4.99元,较前一交易日下跌0.6%,最新总市值为71.21亿元。该股当日开盘5.0元,最高5.02元,最低4.91元,成交额达7182.74万元,换手率为1.03%。出席会议的股东及授权代表共157名,代表股份占公司有表决权股份总数的59.0813%。北京德恒律师事务所对本次会议出具法律意见,认为会议召集召开程序及表决结果合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700035034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000597","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627299142","title":"东北制药营收利润双降背后:传统主业失速与创新转型阵痛并存 外部竞争加剧、内部风险凸显","url":"https://stock-news.laohu8.com/highlight/detail?id=2627299142","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627299142?lang=zh_cn&edition=full","pubTime":"2026-04-16 18:09","pubTimestamp":1776334140,"startTime":"0","endTime":"0","summary":" 近日,东北制药披露2025年年度报告。年报数据显示,公司全年实现营业收入70.75亿元,同比下降5.70%;归母净利润2.60亿元,同比大幅下滑36.54%;扣非归母净利润2.04亿元,同比下降34.53%,核心盈利指标全线走低,且利润降幅远超营收降幅。 作为曾在维生素、抗生素领域占据重要地位的医药老字号企业,东北制药在集采常态化、原料药周期下行、创新药投入三重压力下,陷入传统业务失速、新业务未起、财务隐患浮现的多重困境,公司发展正面临挑战。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-04-16/doc-inhusviy2843118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626191713","title":"东北制药的“双降”困局:仿制药承压,创新药“烧钱”","url":"https://stock-news.laohu8.com/highlight/detail?id=2626191713","media":"新浪证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626191713?lang=zh_cn&edition=full","pubTime":"2026-04-10 18:52","pubTimestamp":1775818320,"startTime":"0","endTime":"0","summary":"在集采常态化与医保控费持续深化的背景下,老牌药企东北制药交出了一份并不乐观的2025年成绩单。年报数据显示,公司全年实现营业收入70.75亿元,同比下降5.70%;归母净利润为2.60亿元,同比大幅下滑36.54%。利润降幅远超营收,反映出公司在核心业务上面临的结构性压力。 东北制药的业务高度依赖传统化学仿制药。在“仿制药难以为继、创新药尚未成型”的夹缝中,东北制药能否熬过这段“青黄不接”的时期,市场将拭目以待。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-04-10/doc-inhtzhty0252049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","000597","BK0191","BK1161","BK1574","159992","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624659332","title":"东北制药(000597)3月31日股东户数4.75万户,较上期减少1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624659332","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624659332?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:20","pubTimestamp":1775208023,"startTime":"0","endTime":"0","summary":"证券之星消息,近日东北制药披露,截至2026年3月31日公司股东户数为4.75万户,较3月10日减少562.0户,减幅为1.17%。在化学制药行业个股中,东北制药股东户数高于行业平均水平,截至3月31日,化学制药行业平均股东户数为3.47万户。从股价来看,2026年3月10日至2026年3月31日,东北制药区间涨幅为0.95%,在此期间股东户数减少562.0户,减幅为1.17%。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202604/03/20260403177778.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202604/03/20260403177778.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260403/32124885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","000597","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624509182","title":"东北制药(000597.SZ)发布2025年度业绩,归母净利润2.6亿元,下降36.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624509182","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624509182?lang=zh_cn&edition=full","pubTime":"2026-04-02 20:29","pubTimestamp":1775132949,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东北制药(000597.SZ)发布2025年年度报告,该公司营业收入为70.75亿元,同比减少5.70%。归属于上市公司股东的净利润为2.6亿元,同比减少36.54%。归属于上市公司股东的扣除非经常性损益的净利润为2.04亿元,同比减少34.53%。基本每股收益为0.18元。此外,拟向全体股东每10股派发现金红利0.55元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424809.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621910089","title":"股市必读:东北制药(000597)3月23日收盘跌7.45%,主力净流出560.69万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621910089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621910089?lang=zh_cn&edition=full","pubTime":"2026-03-24 03:19","pubTimestamp":1774293596,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,东北制药报收于4.72元,下跌7.45%,换手率2.12%,成交量29.95万手,成交额1.44亿元。当日关注点来自交易信息汇总:东北制药3月23日收盘价4.72元,下跌7.45%,连续三日走低,主力资金前10日累计净流出达3991万元。来自资金流向:3月23日主力资金净流出560.69万元,而游资资金净流入1441.42万元,呈现主力与游资分歧态势。交易信息汇总股价提醒3月23日东北制药收盘报4.72元,跌7.45%,当日成交2994.56万元。根据收盘数据统计,该股已连续3日下跌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000597","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620425632","title":"东北制药:截至2026年3月10日持有人数约4.81万","url":"https://stock-news.laohu8.com/highlight/detail?id=2620425632","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620425632?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:53","pubTimestamp":1773838384,"startTime":"0","endTime":"0","summary":"证券之星消息,东北制药(000597)03月17日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止3月10日股东数,谢谢!东北制药回复:投资者您好,根据中国结算深圳分公司提供的数据,截至2026年3月10日,持有人数约4.81万。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800038863.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000597","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620566612","title":"东北制药:DCTY1102注射液是一款适应症为晚期胰腺癌、结直肠癌等恶性肿瘤的自体TCR-T细胞免疫治疗产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2620566612","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620566612?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:53","pubTimestamp":1773838383,"startTime":"0","endTime":"0","summary":"证券之星消息,东北制药03月17日在投资者关系平台上答复投资者关心的问题。公司通过控股鼎成肽源,快速切入细胞治疗前沿领域,建立了TCR-T、CAR-T等技术平台。DCTY1102注射液,是一款适应症为晚期胰腺癌、结直肠癌等恶性肿瘤的自体TCR-T细胞免疫治疗产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800038860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06978","BK0191","BK1574","BK1161","BK0239","000597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616559836","title":"东北制药(000597)披露2026年第一次临时股东会决议公告,3月4日股价下跌1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616559836","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616559836?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:29","pubTimestamp":1772634556,"startTime":"0","endTime":"0","summary":"截至2026年3月4日收盘,东北制药报收于5.12元,较前一交易日下跌1.35%,最新总市值为73.07亿元。近日,东北制药集团股份有限公司披露《2026年第一次临时股东会决议公告》。公告显示,公司于2026年3月4日召开2026年第一次临时股东会,会议采用现场表决与网络投票相结合的方式进行。中小股东中同意占65.4810%,反对占33.9317%。北京德恒律师事务所对本次会议出具法律意见,认为会议召集召开程序及决议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400040328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000597","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613189847","title":"东北制药(000597)披露关于修订《公司章程》的议案,2月24日股价上涨0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613189847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613189847?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:14","pubTimestamp":1771931651,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘,东北制药报收于5.14元,较前一交易日上涨0.19%,最新总市值为73.35亿元。该股当日开盘5.16元,最高5.17元,最低5.11元,成交额达5268.54万元,换手率为0.73%。近日,东北制药集团股份有限公司发布《关于召开2026年第一次临时股东会的通知》。会议将审议《关于修订〈公司章程〉的议案》,该议案为特别决议议案,需经出席股东会的股东所持表决权的2/3以上通过。公司对中小投资者的表决将单独计票并公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400038626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","000597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609438370","title":"东北制药:截至2026年1月30日,持有人数约4.87万","url":"https://stock-news.laohu8.com/highlight/detail?id=2609438370","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609438370?lang=zh_cn&edition=full","pubTime":"2026-02-05 20:52","pubTimestamp":1770295928,"startTime":"0","endTime":"0","summary":"证券之星消息,东北制药(000597)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问:请问1月31日公司股东人数是多少?谢谢!东北制药回复:投资者您好,2026年1月31日为非交易日。根据中国结算深圳分公司提供的数据,截至2026年1月30日,持有人数约4.87万。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500037680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","000597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608885730","title":"东北制药(000597)披露诉讼进展公告,2月2日股价下跌2.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608885730","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608885730?lang=zh_cn&edition=full","pubTime":"2026-02-02 17:56","pubTimestamp":1770026177,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘,东北制药报收于5.15元,较前一交易日下跌2.83%,最新总市值为73.5亿元。该股当日开盘5.27元,最高5.3元,最低5.15元,成交额达9552.82万元,换手率为1.3%。近日,东北制药披露《诉讼进展公告》。涉案金额2,792.5万元已计入公司2024年度损益,案件受理费及执行费合计45.85万元,预计减少2025年度损益。截至公告日,相关款项已扣划完毕。公司及控股子公司无其他应披露未披露的重大诉讼或仲裁事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200026699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601611403","title":"东北制药:截至2025年12月31日持有人数约4.74万","url":"https://stock-news.laohu8.com/highlight/detail?id=2601611403","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601611403?lang=zh_cn&edition=full","pubTime":"2026-01-08 20:48","pubTimestamp":1767876534,"startTime":"0","endTime":"0","summary":"证券之星消息,东北制药(000597)01月07日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截至12月31日公司股东人数多少?谢谢!东北制药回复:投资者您好,根据中国结算深圳分公司提供的数据,截至2025年12月31日,持有人数约4.74万。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800036818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601279813","title":"东北制药(000597)披露非独立董事辞职暨选举职工代表董事公告,1月6日股价上涨0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601279813","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601279813?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:32","pubTimestamp":1767709938,"startTime":"0","endTime":"0","summary":"近日,东北制药集团股份有限公司发布关于非独立董事辞职暨选举职工代表董事的公告。公告称,公司董事会收到非独立董事王新鹏先生的书面辞职报告,因公司治理结构调整,王新鹏先生辞去第十届董事会非独立董事职务,辞职后仍担任公司其他职务。王新鹏先生未持有公司股份,其辞职不影响董事会正常运作。公司于2026年1月4日召开职工代表团(组)长联席会,选举王新鹏先生为第十届董事会职工代表董事,任期至本届董事会任期届满。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600042608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593472534","title":"东北制药:截至2025年12月19日持有人数约4.80万","url":"https://stock-news.laohu8.com/highlight/detail?id=2593472534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593472534?lang=zh_cn&edition=full","pubTime":"2025-12-24 20:51","pubTimestamp":1766580717,"startTime":"0","endTime":"0","summary":"证券之星消息,东北制药(000597)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司截止到12.20日的股东人数是多少?谢谢!东北制药回复:投资者您好,2025年12月20日为非交易日。根据中国结算深圳分公司提供的数据,截至2025年12月19日,持有人数约4.80万。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400037431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593022499","title":"东北制药最新公告:开展股东回馈活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2593022499","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593022499?lang=zh_cn&edition=full","pubTime":"2025-12-23 18:30","pubTimestamp":1766485851,"startTime":"0","endTime":"0","summary":"东北制药(000597.SZ)公告称,为感谢股东支持,提高股东对公司内在价值的理解,同时推广自有美妆品牌,公司将开展股东回馈活动。活动时间为2025年12月25日至28日,参与范围为2025年12月8日收市时登记在册的持有公司股份500股(含)以上的股东。活动内容包含“买1得4”和专享9折优惠。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300030765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597","BK0239","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592164215","title":"东北制药:截至2025年12月10日持有人数约4.80万","url":"https://stock-news.laohu8.com/highlight/detail?id=2592164215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592164215?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:52","pubTimestamp":1766148750,"startTime":"0","endTime":"0","summary":"证券之星消息,东北制药(000597)12月18日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2025年12月10日股东人数是多少?东北制药回复:投资者您好,根据中国结算深圳分公司提供的数据,截至2025年12月10日,持有人数约4.80万。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900036489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000597","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591648642","title":"东北制药(000597)披露取消监事会及修订公司章程等议案获股东会通过,12月15日股价下跌1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591648642","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591648642?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:28","pubTimestamp":1765808938,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘,东北制药报收于5.27元,较前一交易日下跌1.31%,最新总市值为75.21亿元。根据近日发布的公告,东北制药于2025年12月15日召开2025年第二次临时股东会,审议通过了关于变更公司注册资本、股份总数、取消监事会并修订《公司章程》的议案,以及修订多项公司治理制度的议案,包括股东会议事规则、董事会议事规则、独立董事工作细则等。北京德恒律师事务所对本次会议出具法律意见,认为决议合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500036014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777480449588,"stockEarnings":[{"period":"1week","weight":-0.0312},{"period":"1month","weight":-0.0659},{"period":"3month","weight":-0.0677},{"period":"6month","weight":-0.1063},{"period":"1year","weight":-0.0121},{"period":"ytd","weight":-0.0498}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.047},{"period":"3month","weight":-0.0121},{"period":"6month","weight":0.0386},{"period":"1year","weight":0.2498},{"period":"ytd","weight":0.0349}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"东北制药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"47538人(较上一季度减少1.17%)","perCapita":"29643股","listingDate":"1996-05-23","address":"辽宁省沈阳市铁西区经济技术开发区昆明湖街","registeredCapital":"142708万元","survey":" 东北制药集团股份有限公司的主营业务是化学制药、医药商业、医药工程、生物医药等板块。公司的主要产品是维生素类、抗感染类、生殖系统和性激素类产维生素C系列、维生素B1、维生素B6和左卡尼汀系列、磷霉素系列、阿奇霉素系列、金刚烷胺系列、盐酸小檗碱、氯霉素、卡孕栓、卡前列素氨丁三醇、左炔诺孕酮片、他达拉非片、盐酸达泊西汀、吡拉西坦系列、左乙拉西坦系列、长春西汀、盐酸吗啡注射液、盐酸吗啡片、盐酸羟考酮注射液、复方甘草系列、氨酚待因片、克度/齐多夫定片、克度/齐多夫定胶囊、依非韦伦、齐多拉米双夫定片、地衣芽孢杆菌、铝碳酸镁咀嚼片、复方丙谷胺西咪替丁片、对乙酰氨基酚片、去痛片、非那西丁、普瑞巴林、那可丁糖浆、枸磺新啶片、甲硝唑片、替硝唑片、马来酸氨氯地平、维格列汀、恩格列净、氨酚伪麻那敏口服溶液、氨酚烷胺片、HIV、HBV、HCV、HPV、TB分子诊断试剂、养颜护肤系列化妆品、药食同源功能饼干、细胞治疗产品、神经系统类产品、抗艾滋病类产品、消化道类产品、麻精及含麻系列类产品、其他普药类产品、体外诊断试剂类产品、大健康领域产品。公司是中国重要的药品生产与出口基地、中国最大的单体制剂生产基地之一、中国麻精药品和抗艾药物生产基地、国家大宗原料药和医药中间体智能制造示范工厂、国家级企业技术中心和创新药物孵化基地、国际医药食品市场主流供应商。","listedPrice":6.68},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东北制药(000597)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东北制药(000597)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东北制药,000597,东北制药股票,东北制药股票老虎,东北制药股票老虎国际,东北制药行情,东北制药股票行情,东北制药股价,东北制药股市,东北制药股票价格,东北制药股票交易,东北制药股票购买,东北制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东北制药(000597)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东北制药(000597)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}